Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer. [electronic resource]
Producer: 19870219Description: 61-6 p. digitalISSN:- 0361-5960
- Actuarial Analysis
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Brain Neoplasms -- secondary
- Carcinoma, Small Cell -- drug therapy
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Random Allocation
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.